Solution-based and innovative physicians, physician assistants, nurse practitioners and healthcare providers have attained safe and efficacious pain management outcomes without the use of narcotics.
These pain management leaders are the change agents needed to reduce opioid addiction and overdoses while effectively providing pain management.
The following case studies demonstrate successful pain management outcomes that have significantly improved patient satisfaction and quality of life.
We welcome the opportunity to feature your case study. If you have a case study you’d like to feature, please email us at info@biomedpharmacy.com.
NEUROPATHY
Diabetic Peripheral Neuropathy
• The patient is a 41-year-old female with a history of diabetes who complains of severe foot pain that has been going on for many years. The patient reports that the pain is burning type, throbbing, tingling, and hotness like. The patient reports that the pain is a 9/10 on a VAS scale.
• She is reported to have low level of relief by pain medications and aggravated by standing and walking. She reports that her feet swell and become hot to the touch when the pain flairs. Her medications include Amitriptyline 50 mg p.o. q.h.s., Gabapentin 600 p.o. bid, Aspirin 81 mg q.d., Losartan 50 mg half a tablet two times a day, Metformin 1000 mg one tablet two times a day, Simvastatin 40 mg half a tablet q.h.s. and Vicodin ES 7.5/750 mg p.o. 1-2 tablets every 4 to 6 hours p.r.n.
• The patient was not finding adequate pain relief from the Vicodine ES as prescribed and she reportedly began taking two-four pills every 2-3 hours. The patient was brought into the pharmacy by her sister and referred by one of the DPMs in our area.
• With the agreement of the DPM the patient was put on a topical pain compound containing: Ketamine 10%, Gabapentin 6%, Amitriptyline 2%, Baclofen 2%, Cyclobenzaprine 2%, Diclofenac 3%, Lidocaine 5% QID. Her oral gabapentin and amitriptyline were tapered down and discontinued after 30 days and she is down to taking one Vicodine ES for breakthrough and not exceeding 2 tabs a day.
